The most-clicked news item for Thursday was “Why Amgen, Inc.’s Kyprolis FOCUS Failure Is a Big Deal.” In... read more
The most-clicked news item for Thursday was “Why Amgen, Inc.’s Kyprolis FOCUS Failure Is a Big Deal.” In... read more
The most-clicked news item for Wednesday was “BMS, Pfizer pull out all the stops to give Eliquis sales a Q2 jolt.”... read more
The most-clicked news item for Tuesday was “Boehringer to cut costs by 15%.” After announcing... read more
The most-clicked news item for Monday was “FDA Accepts First-Ever Biosimilar Application for Monoclonal Antibody.”... read more
The most-clicked news item for Friday was “Pfizer confronts surge of lawsuits over Lipitor.” Over the... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,